Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Munitz

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Pharmacology & Therapeutics|November 17, 2009
Inhibitory receptors on myeloid cells: new targets for therapy?Ariel Munitz
The Journal of Allergy and Clinical Immunology|June 15, 2010
Mutations in CCR3 render it missing in actionPaige Lacy, Ariel Munitz
Cellular & Molecular Immunology|May 30, 2017
Harnessing class II histone deacetylases in macrophages to combat breast cancerHadar Reichman, Ariel Munitz
Nature Reviews. Immunology|July 9, 2024
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and diseaseIsabelle C Arnold, Ariel Munitz
The Journal of Allergy and Clinical Immunology|April 3, 2012
T(H)9 cells: in front and beyond T(H)2Ariel Munitz, Paul S Foster
Nature Immunology|February 20, 2019
Alarming eosinophils to combat tumorsAriel Munitz, Simon Patrick Hogan
Nature Cancer|February 28, 2024
ATX restricts anti-tumor eosinophil responsesSharon Grisaru-Tal, Ariel Munitz
Cancer Cell|December 16, 2022
T cell-eosinophil crosstalk-A new road for effective immune checkpoint blockade in breast cancer?Sharon Grisaru-Tal, Ariel Munitz
Recent Patents on Inflammation & Allergy Drug Discovery|September 3, 2010
Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseasesMiguel L Stein, Ariel Munitz
American Journal of Respiratory Cell and Molecular Biology|December 30, 2017
Is Asthma Paying the Toll?Danielle Karo-Atar, Ariel Munitz
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Pharmacology & Therapeutics|November 17, 2009
Inhibitory receptors on myeloid cells: new targets for therapy?Ariel Munitz
The Journal of Allergy and Clinical Immunology|June 15, 2010
Mutations in CCR3 render it missing in actionPaige Lacy, Ariel Munitz
Cellular & Molecular Immunology|May 30, 2017
Harnessing class II histone deacetylases in macrophages to combat breast cancerHadar Reichman, Ariel Munitz
Nature Reviews. Immunology|July 9, 2024
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and diseaseIsabelle C Arnold, Ariel Munitz
The Journal of Allergy and Clinical Immunology|April 3, 2012
T(H)9 cells: in front and beyond T(H)2Ariel Munitz, Paul S Foster
Nature Immunology|February 20, 2019
Alarming eosinophils to combat tumorsAriel Munitz, Simon Patrick Hogan
Nature Cancer|February 28, 2024
ATX restricts anti-tumor eosinophil responsesSharon Grisaru-Tal, Ariel Munitz
Cancer Cell|December 16, 2022
T cell-eosinophil crosstalk-A new road for effective immune checkpoint blockade in breast cancer?Sharon Grisaru-Tal, Ariel Munitz
Recent Patents on Inflammation & Allergy Drug Discovery|September 3, 2010
Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseasesMiguel L Stein, Ariel Munitz
American Journal of Respiratory Cell and Molecular Biology|December 30, 2017
Is Asthma Paying the Toll?Danielle Karo-Atar, Ariel Munitz
Pageof 10